Correlation Between Oncopeptides and Gapwaves

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Oncopeptides and Gapwaves at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Oncopeptides and Gapwaves into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Oncopeptides AB and Gapwaves AB Series, you can compare the effects of market volatilities on Oncopeptides and Gapwaves and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Oncopeptides with a short position of Gapwaves. Check out your portfolio center. Please also check ongoing floating volatility patterns of Oncopeptides and Gapwaves.

Diversification Opportunities for Oncopeptides and Gapwaves

0.37
  Correlation Coefficient

Weak diversification

The 3 months correlation between Oncopeptides and Gapwaves is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Oncopeptides AB and Gapwaves AB Series in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Gapwaves AB Series and Oncopeptides is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Oncopeptides AB are associated (or correlated) with Gapwaves. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Gapwaves AB Series has no effect on the direction of Oncopeptides i.e., Oncopeptides and Gapwaves go up and down completely randomly.

Pair Corralation between Oncopeptides and Gapwaves

Assuming the 90 days trading horizon Oncopeptides AB is expected to under-perform the Gapwaves. In addition to that, Oncopeptides is 2.17 times more volatile than Gapwaves AB Series. It trades about -0.07 of its total potential returns per unit of risk. Gapwaves AB Series is currently generating about -0.04 per unit of volatility. If you would invest  1,966  in Gapwaves AB Series on September 14, 2024 and sell it today you would lose (646.00) from holding Gapwaves AB Series or give up 32.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy99.63%
ValuesDaily Returns

Oncopeptides AB  vs.  Gapwaves AB Series

 Performance 
       Timeline  
Oncopeptides AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Oncopeptides AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in January 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Gapwaves AB Series 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Gapwaves AB Series has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Oncopeptides and Gapwaves Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Oncopeptides and Gapwaves

The main advantage of trading using opposite Oncopeptides and Gapwaves positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Oncopeptides position performs unexpectedly, Gapwaves can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Gapwaves will offset losses from the drop in Gapwaves' long position.
The idea behind Oncopeptides AB and Gapwaves AB Series pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Global Correlations
Find global opportunities by holding instruments from different markets
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk